MedPath

The comparison of the effect of N-acetylcysteine and angiotensin- converting enzyme inhibitors with angiotensin-converting enzyme inhibitors alone to control blood pressure in hypertensive patients

Phase 3
Conditions
Blood pressure.
Essential (primary) hypertension
Registration Number
IRCT2014022616750N1
Lead Sponsor
Deputy of research and technology, Shahrekord university of medical sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
126
Inclusion Criteria

The inclusion criteria: having age of 18 years old or more; systolic blood pressure of 140 mmHg or higher despite of taking ACEI.
The people who are afflicted with Cystinuria; has kidney stones especially Cysteine stones; show severe sensitivity to ACEI and NAC and also the patients who need the other antihypertensive drugs besides ACEI to control their blood pressure are to be excluded from the study.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Blood pressure. Timepoint: Before the study, every 5-7 days during the study for two months. Method of measurement: Measured based on mmHg by Mercury barometer.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath